298 related articles for article (PubMed ID: 28293776)
41. Thresholds in disease activity for switching biologics in rheumatoid arthritis patients: experience from a large U.S. cohort.
Zhang J; Shan Y; Reed G; Kremer J; Greenberg JD; Baumgartner S; Curtis JR
Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1672-9. PubMed ID: 21954144
[TBL] [Abstract][Full Text] [Related]
42. Benefit of biologics initiation in moderate versus severe rheumatoid arthritis: evidence from a United States registry.
Kavanaugh A; Keystone E; Greenberg JD; Reed GW; Griffith JM; Friedman AW; Saunders KC; Ganguli A
Rheumatology (Oxford); 2017 Jul; 56(7):1095-1101. PubMed ID: 28340006
[TBL] [Abstract][Full Text] [Related]
43. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.
Tanaka E; Mannalithara A; Inoue E; Hara M; Tomatsu T; Kamatani N; Singh G; Yamanaka H
Ann Rheum Dis; 2008 Aug; 67(8):1153-8. PubMed ID: 17971459
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort.
Khanna D; Oh M; Furst DE; Ranganath V; Gold RH; Sharp JT; Park GS; Keystone EC; Paulus HE;
Arthritis Rheum; 2007 Apr; 57(3):440-7. PubMed ID: 17394230
[TBL] [Abstract][Full Text] [Related]
45. Sustained clinical remission of rheumatoid arthritis and its predictive factors in an unselected adult Chinese population from 2009 to 2018.
Xie W; Li J; Zhang X; Sun X; Zhang Z
Int J Rheum Dis; 2019 Sep; 22(9):1670-1678. PubMed ID: 31297977
[TBL] [Abstract][Full Text] [Related]
46. Hand function tests are important and sensitive tools for assessment of treatment response in patients with rheumatoid arthritis.
Eberhardt K; Sandqvist G; Geborek P
Scand J Rheumatol; 2008; 37(2):109-12. PubMed ID: 18415767
[TBL] [Abstract][Full Text] [Related]
47. Use of clinical scores to guide therapeutic decisions in patients with rheumatoid arthritis in daily care.
Malysheva O; Bedrich A; Kuipers JG; Kleine H; Wolff B; Baerwald CG
Clin Exp Rheumatol; 2015; 33(2):255-8. PubMed ID: 25896474
[TBL] [Abstract][Full Text] [Related]
48. Rapid improvement of Clinical Disease Activity Index (CDAI) at 3 months predicts a preferable CDAI outcome at 1 year in active rheumatoid arthritis patients treated with tocilizumab: results from an observational investigation of daily clinical practice.
Kawashiri SY; Nishino A; Suzuki T; Nakashima Y; Horai Y; Ueki Y; Aramaki T; Fujikawa K; Nakashima M; Okada A; Migita K; Mizokami A; Matsuoka N; Mine M; Sakito S; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Aoyagi K; Eguchi K; Kawakami A
Clin Exp Rheumatol; 2016; 34(5):808-812. PubMed ID: 27384149
[TBL] [Abstract][Full Text] [Related]
49. Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study.
Mancarella L; Bobbio-Pallavicini F; Ceccarelli F; Falappone PC; Ferrante A; Malesci D; Massara A; Nacci F; Secchi ME; Manganelli S; Salaffi F; Bambara ML; Bombardieri S; Cutolo M; Ferri C; Galeazzi M; Gerli R; Giacomelli R; Grassi W; Lapadula G; Cerinic MM; Montecucco C; Trotta F; Triolo G; Valentini G; Valesini G; Ferraccioli GF;
J Rheumatol; 2007 Aug; 34(8):1670-3. PubMed ID: 17611987
[TBL] [Abstract][Full Text] [Related]
50. Achievement of Remission and Low Disease Activity Definitions in Patients with Rheumatoid Arthritis in Clinical Practice: Results from the NOR-DMARD Study.
Uhlig T; Lie E; Norvang V; Lexberg ÅS; Rødevand E; Krøll F; Kalstad S; Olsen IC; Kvien TK
J Rheumatol; 2016 Apr; 43(4):716-23. PubMed ID: 26879358
[TBL] [Abstract][Full Text] [Related]
51. Characteristics of patients with rheumatoid arthritis in Qatar: a cross-sectional study.
Lutf A; Poil AR; Hammoudeh M
Int J Rheum Dis; 2014 Jan; 17(1):63-5. PubMed ID: 24472269
[TBL] [Abstract][Full Text] [Related]
52. Normalisation of physical function by infliximab in patients with RA: factors associated with normal physical function.
Nagasawa H; Kameda H; Sekiguchi N; Amano K; Takeuchi T
Clin Exp Rheumatol; 2010; 28(3):365-72. PubMed ID: 20525444
[TBL] [Abstract][Full Text] [Related]
53. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.
Welsing PM; Fransen J; van Riel PL
Arthritis Rheum; 2005 Sep; 52(9):2616-24. PubMed ID: 16142762
[TBL] [Abstract][Full Text] [Related]
54. Adding ultrasound to treat-to-target shows no benefit in achieving clinical remission nor in slowing radiographic progression in rheumatoid arthritis: results from a multicenter prospective cohort.
Sepriano A; Ramiro S; Landewé R; van der Heijde D; Ohrndorf S; FitzGerald O; Backhaus M; Larché M; Homik J; Saraux A; Hammer HB; Terslev L; Østergaard M; Burmester G; Combe B; Dougados M; Hitchon C; Boire G; Lambert RG; Dadashova R; Paschke J; Hutchings EJ; Maksymowych WP
Clin Rheumatol; 2024 Jun; 43(6):1833-1844. PubMed ID: 38684600
[TBL] [Abstract][Full Text] [Related]
55. Effect of Adherence to Protocolized Targeted Intensifications of Disease-modifying Antirheumatic Drugs on Treatment Outcomes in Rheumatoid Arthritis: Results from an Australian Early Arthritis Cohort.
Wabe NT; Sorich MJ; Wechalekar MD; Cleland LG; McWilliams L; Lee AT; Spargo LD; Metcalf RG; Hall C; Proudman SM; Wiese MD
J Rheumatol; 2016 Sep; 43(9):1643-9. PubMed ID: 27422892
[TBL] [Abstract][Full Text] [Related]
56. Factors associated with the intensification of treatment in rheumatoid arthritis in clinical practice.
Naranjo A; Cáceres L; Hernández-Beriaín JÁ; Francisco F; Ojeda S; Talaverano S; Nóvoa-Medina J; Martín JA; Delgado E; Trujillo E; Álvarez F; Magdalena L; Rodríguez-Lozano C
Rheumatol Int; 2015 Nov; 35(11):1851-5. PubMed ID: 26238094
[TBL] [Abstract][Full Text] [Related]
57. Tight control of rheumatoid arthritis in a resource-constrained setting: a randomized controlled study comparing the clinical disease activity index and simplified disease activity index.
Hodkinson B; Musenge E; Tikly M
Rheumatology (Oxford); 2015 Jun; 54(6):1033-8. PubMed ID: 25431484
[TBL] [Abstract][Full Text] [Related]
58. No predictive effect of body mass index on clinical response in patients with rheumatoid arthritis after 24 weeks of biological disease-modifying antirheumatic drugs: a single-center study.
Kim SK; Choe JY; Park SH; Lee H
Clin Rheumatol; 2016 May; 35(5):1129-36. PubMed ID: 26932795
[TBL] [Abstract][Full Text] [Related]
59. Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity.
Plasencia C; Wolbink G; Krieckaert CL; Kneepkens EL; Turk S; Jurado T; Martínez-Feito A; Navarro-Compán V; Bonilla G; Villalba A; Peiteado D; Nuño L; Martín-Mola E; Nurmohamed MT; van der Kleij D; Rispens T; Pascual-Salcedo D; Balsa A
Clin Exp Rheumatol; 2016; 34(4):655-62. PubMed ID: 27214767
[TBL] [Abstract][Full Text] [Related]
60. Clinical presentation, burden of disease and treatment in young-onset and late-onset rheumatoid arthritis: a matched-pairs analysis taking age and disease duration into account.
Huscher D; Sengler C; Gromnica-Ihle E; Bischoff S; Eidner T; Ochs W; Richter J; Zink A
Clin Exp Rheumatol; 2013; 31(2):256-62. PubMed ID: 23305590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
